This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing CAH (Congenital Adrenal Hyperplasia) and therapies in development, including crinecerfont and tildacerfont

Ticker(s): SPRB, NBIX

Who's the expert?

Institution: UT Southwestern

  • Professor of Pediatrics and Director of Pediatric endocrinlogy at UT Southwestern
  • Treats 150 pediatric CAH patients, Site PI for crinecerfont,
  • Research interests include genetic diseases of steroid hormone biosynthesis and metabolism, type 1 and 2 diabetes

Interview Goal
Discuss clinical data for crinecerfont and outlook and tildacerfont trials in adult and pediatric CAH

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.